{
  "id": 7587088,
  "title": "Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results",
  "url": "https://urgent.news/2026/09/15/bezisterim-may-help-with-some-long-covid-symptoms-drugs-developer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T15:54:14.000Z",
  "source": {
    "name": "The Sick Times",
    "slug": "the-sick-times",
    "url": "https://thesicktimes.org/2026/09/15/bezisterim-may-help-with-some-long-covid-symptoms-drugs-developer-reports-in-early-trial-results/"
  },
  "original_language": "en",
  "account": "BioVie, the developer of a novel drug called bezisterim, has shared early results from a phase 2 clinical trial showing the potential for the drug to alleviate symptoms of Long COVID, such as fatigue, post-exertional malaise, and neurological issues. While the trial's findings require further analysis and peer-review, they are among the most promising results reported thus far for Long COVID, according to the study's expert advisors. The phase 2 trial, named ADDRESS-LC, involved 203 participants who took the oral drug or a placebo for three months. The investigators designed the trial as a \"proof-of-concept\" study, evaluating 22 different metrics to measure bezisterim's impact. The data showed a clear direction toward improving key symptoms, providing hope for the community as previous trials had failed. BioVie plans to use these results to inform a larger, phase 3 study and seek accelerated FDA approval. The company aims to include more severe Long COVID patients in this trial, possibly with a decentralized arm allowing remote participation.",
  "summary": "While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. The post Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results first appeared on The Sick Times .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "BioVie reports phase 2 long COVID trial results",
        "url": "https://urgent.news/2026/09/15/biovie-reports-phase-2-long-covid-trial-results",
        "published": "2026-09-15T11:36:40.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}